Cebranopadol not checked

Adneuris Therapeutics, Inc. · Tris Pharma, Inc. · GRT6005 · TRN-228

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
13 active
35 in total · 17 in the EU
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“Participants receive Cebranopadol 400 mcg once per day for 14 days or until pain resolves, whichever occurs first.”In the company’s words, NCT07845071 on ClinicalTrials.gov
Tested for
Pain (2 trials), Chronic Pain, Opioid Withdrawal (Disorder), Opioid Use Disorder
Main trialPhase 3
“The purpose of this study is to evaluate the safety and effectiveness of cebranopadol in treating acute pain.”In the company’s words, NCT07845071 on ClinicalTrials.gov
Other names
GRT6005 · TRN-228 · Experimental · Treatment Phase · Morphine

Other drugs for Pain

All 61 drugs for Pain

Coming up2

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials35

TrialPhaseCompletesWhat it tests
Phase 3Recruiting Jan 2027 An Open-Label, Safety and Efficacy Study of Cebranopadol in Participants With Acute Pain With Surgical or Non-Surgical Origin
Phase 2Recruiting Mar 2027 A Study of Cebranopadol for Opioid Withdrawal Symptoms in Adults With Chronic Pain
Phase 3Terminated 16 Oct 2015 CORAL - Cebranopadol Versus Morphine Prolonged-release in Patients With Chronic Moderate to Severe Pain Related to Cancer
Phase 3Completed Apr 2016 CORAL XT - Open-label Extension Trial of the CORAL Trial
Phase 3Completed 30 Dec 2024 A Study of Cebranopadol for the Treatment of Acute Pain After Abdominoplasty
Phase 3Completed 31 Jan 2025 A Study of Cebranopadol for the Treatment of Acute Pain After Bunionectomy
Phase 2Completed Aug 2009 Bunionectomy Trial With GRT6005
Phase 2Completed May 2010 Painful Diabetic Polyneuropathy Trial With a New Centrally Acting Analgesic
Phase 2Completed Dec 2011 Assessment of GRT6005 in Painful Osteoarthritis of the Knee
Phase 2Completed Jan 2012 Safety and Efficacy of GRT6005 in Pain Due to Diabetic Polyneuropathy
Phase 2Completed Apr 2014 Safety and Efficacy Study of GRT6005 in Patients With Osteoarthritis (OA) Knee Pain
Phase 2Completed Jul 2014 Efficacy and Safety of GRT6005 in Patients With Chronic Low Back Pain.
Phase 2Completed Jan 2015 Cebranopadol Efficacy and Safety in Diabetic Patients Suffering From Chronic Pain Caused by Damage to the Nerves
Phase 1Completed 27 Nov 2013 Evaluation of the Effects of Multiple Doses of Cebranopadol on the Electrical Activity of the Heart in Healthy Subjects
Phase 1Completed 17 Sep 2014 A Clinical Study to Evaluate the Effect of Renal Impairment on the Pharmacokinetics of Cebranopadol
Phase 1Completed 12 Jul 2022 Assessment of Abuse Potential of Cebranopadol in Humans
Phase 1Completed 30 Mar 2023 Cebranopadol Effects on Ventilatory Drive, Central Nervous System (CNS) and Pain.
Phase 1Completed 6 Nov 2024 A Study to Assess the Abuse Potential of Intranasal Cebranopadol
Phase 2Ended not given MORPHINE PHARMACOKINETICS AND –DYNAMICS IN HEALTHY VOLUNTEERS AND PATIENTS WITH OBESITY AND OBSTRUCTIVE SLEEP APNOEA. -AN INVESTIGATOR INITIATED, CLINICAL STUDY OF THE IMPACT OF OBESITY AND SLEEP APNOEA ON THE PHARMACOLOGY OF MORPHINE
Phase 4Authorised not given Palliation of Dyspnea and Cough using Morphine in patients with Fibrotic Interstitial Lung Disease
Phase 3Authorised not given Effekten av intrathekalt morfin eller intravenöst lidokain på postoperativ återhämtning efter robotassisterad övre urologisk kirurgi. Randomiserad assessor-blindad multicenterstudie.
Phase 2/3Authorised not given AntaMIn - Pain reduction for limb injuries in pediatric emergency departments: A Randomised Clinical Trial comparing intranasal Fentanyl or intranasal Ketamine to oral morphine
Phase 4Ended not given Efficacy of Intrathecal Morphine for Postoperative Analgesia with or without Suprainguinal Fascia Iliaca Block After Total Hip Arthroplasty: A Double-Blind Randomized Clinical Trial
Phase 4Authorised not given Clairance de la morPHinE et filtration glomérulaire chez le Drepanocytaire en crise en REAnimation_PHEDREA
Phase 3Ended not given Risk-benefit analysis of intrathecal morphine administration to patients undergoing surgical treatment of proximal femoral fracture (monocentric, single-blinded, randomized clinical study compared to standard treatment)
Phase 4Ended not given Determining the clinical relevance of the interaction between enzalutamide and the opioid morphine and the DOAC edoxaban to improve rational pharmacological care of patients with prostate cancer
Phase 4Ended not given Midazolam and mORPHine to alleviate symptoms at the End of life in patients on acUte geriatric wardS (MORPHEUS study)
Phase 2Ended not given Morphine effects on stress response and social interaction – an exploratory randomized controlled experimental medicine study
Phase 4Authorised not given Affective effects of pre-surgery opioids (AFFECT2): a randomized, doubleblind placebo-controlled trial
Phase 4Authorised not given MOTHER trial: Efficacy and safety of low-dose intrathecal morphine following planned caesarean section - a randomised, blinded, clinical, controlled, multicentre trial.
Phase 4Authorised not given Intrathecal drug delivery systems versus comprehensive medical management for severe cancer pain: a randomized controlled trial
Phase 3Authorised not given Sustained-release oral morphine to alleviate persistent dyspnea in patients with chronic respiratory insufficiency due to amyotrophic lateral sclerosis outside the administration of ventilatory assistance: prospective multicenter randomized, placebo-controlled study, parallel arms. (OPIDYS-ALS).
Phase 4Authorised not given TRAMORNOT: Tramadol versus morphine in postoperative analgesia after laparoscopic abdominal surgery: a randomized controlled trial
Phase 4Authorised not given Morphine for resting breathlessness in severe illness and palliative care (MORE-B): a randomized clinical trial
Phase 4Authorised not given POISON – Perioperative Safety and Effective Opioid Dosing in Chronic Opioid Use – a Randomized Clinical Study
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow Cebranopadol

Following is part of Solo: you see every change to Cebranopadol the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in